The epidemiology of antibiotic resistance in Campylobacter.
Antibiotic resistance, particularly with the fluoroquinolones and macrolide antibiotics, has now emerged globally with thermophilic campylobacters, including Campylobacter jejuni and C. coli, giving rise to concerns about how these organisms have acquired such resistance characteristics, as well as consequences for human and animal treatment. This review examines (i) the clinical epidemiology of antibiotic resistance in human and animal thermophilic campylobacters, (ii) an update on resistance rates globally, (iii) surveillance of antimicrobial resistance in campylobacters originating from animals, particularly poultry, (iv) the role of the environment in the acquisition and transmission of antibiotic-resistant campylobacters, as well as (v) issues of biocide resistance in campylobacters.
Moore
John E
JE
Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, Northern Ireland, UK. jemoore@niphl.dnet.co.uk
Barton
Mary D
MD
Blair
Iain S
IS
Corcoran
Deborah
D
Dooley
James S G
JS
Fanning
Séamus
S
Kempf
Isabelle
I
Lastovica
Albert J
AJ
Lowery
Colm J
CJ
Matsuda
Motoo
M
McDowell
David A
DA
McMahon
Ann
A
Millar
B Cherie
BC
Rao
Juluri R
JR
Rooney
Paul J
PJ
Seal
Bruce S
BS
Snelling
William J
WJ
Tolba
Ola
O
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects*; D002169:Campylobacter Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000662:veterinary; D004351:Drug Resistance / Q000235:genetics*; D006801:Humans
D000900:Anti-Bacterial Agents